<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Pediatr</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Pediatr</journal-id>
      <journal-title-group>
        <journal-title>BMC Pediatrics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2431</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25062701</article-id>
      <article-id pub-id-type="pmc">4113662</article-id>
      <article-id pub-id-type="publisher-id">1471-2431-14-190</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2431-14-190</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Milani</surname>
            <given-names>Gregorio Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>milani.gregoriop@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Edefonti</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>alberto.edefonti@policlinico.mi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Tardini</surname>
            <given-names>Giacomo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>giacomo.tardini@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Arturi</surname>
            <given-names>Elisa</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>elisa.arturi@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Cinnante</surname>
            <given-names>Claudia Maria</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>claudia.cinnante@policlinico.mi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Laicini</surname>
            <given-names>Emanuela Anna</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>emanuela.laicini@policlinico.mi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Leva</surname>
            <given-names>Ernesto</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>ernesto.leva@policlinico.mi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Cappellari</surname>
            <given-names>Alberto Maria</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>albertocapp@yahoo.it</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Agostoni</surname>
            <given-names>Carlo</given-names>
          </name>
          <xref ref-type="aff" rid="I6">6</xref>
          <email>agostoc2@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A10">
          <name>
            <surname>Fossali</surname>
            <given-names>Emilio Filippo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>emilio.fossali@policlinico.mi.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Foundation IRCCS Ca&#x2019; Granda, Ospedale Maggiore Policlinico, Pediatric Emergency Department, Milan, Italy</aff>
      <aff id="I2"><label>2</label>Foundation IRCCS Ca&#x2019; Granda, Ospedale Maggiore Policlinico, Pediatric Nephrology and Dialysis Department, Milan, Italy</aff>
      <aff id="I3"><label>3</label>Foundation IRCCS Ca&#x2019; Granda, Ospedale Maggiore Policlinico, Neuroradiology Department, Milan, Italy</aff>
      <aff id="I4"><label>4</label>Foundation IRCCS Ca&#x2019; Granda, Ospedale Maggiore Policlinico, Pediatric Surgery Department, Milan, Italy</aff>
      <aff id="I5"><label>5</label>Foundation IRCCS Ca&#x2019; Granda, Ospedale Maggiore Policlinico, Department of Neuroscience and Mental Health, Milan, Italy</aff>
      <aff id="I6"><label>6</label>Department of Clinical Sciences and Community Health, University of Milan, IRCCS Ospedale Maggiore Policlinico, Pediatric Clinic 2, Milan, Italy</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <volume>14</volume>
      <fpage>190</fpage>
      <lpage>190</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>10</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Milani et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Milani et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2431/14/190"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Posterior reversible encephalopathy syndrome is a potentially reversible clinicoradiologic syndrome characterized by headache, mental confusion, visual disturbances and seizures associated with posterior cerebral lesions on radiological imaging. Prompt treatment of this condition is mandatory to avoid severe irreversible complications.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report a 9-year-old boy with arterial hypertension and headache as unique clinical presentation of posterior reversible encephalopathy syndrome.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Severe and isolated headache associated with arterial hypertension can be the unique clinical presentation of posterior reversible encephalopathy syndrome. This syndrome must be considered even in absence of all typical symptoms to prevent the progression of a potentially life threatening condition.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Posterior reversible encephalopathy syndrome</kwd>
        <kwd>Arterial hypertension</kwd>
        <kwd>Headache</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Posterior reversible encephalopathy syndrome (PRES), first described by Hinchey <italic>et al</italic>. in 1996
[<xref ref-type="bibr" rid="B1">1</xref>], is a clinicoradiological condition presenting with headache, seizures, alterations of conscious level and loss of vision, accompanied by characteristic Magnetic Resonance Imaging (MRI) findings. Both the neurological and radiological features are potentially reversible
[<xref ref-type="bibr" rid="B2">2</xref>]. Nevertheless several complications as status epilepticus, intracranial hemorrhage, and massive ischemic infarction have been reported in association with this syndrome
[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. The removal of the underlying causes is essential to prevent long term sequelae
[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>We report a child with PRES presenting as hypertension and severe headache, with rapid clinical and neuroimaging normalization after a prompt treatment.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A previously normotensive 9-year-old boy was admitted to the Pediatric Emergency Department with bilateral periorbital edema and gross hematuria for 24&#xA0;hours.</p>
      <p>20 days before, he had experienced an episode of mild sore throat spontaneously recovered.</p>
      <p>On admission general conditions, neurological and visual examinations were normal except for periorbital edemas. Axillary temperature was 36.9&#xB0;C, oxygen saturation 98%, heart rate 88 beats per minute, body weight 35&#xA0;kg (two more than the previous week), and body height 1.350&#xA0;m. Blood pressure was increased with systolic values ranging between 125 and 130&#xA0;mmHg and diastolic values ranging between 80 and 85&#xA0;mmHg (stage 1 hypertension: 95<sup>th</sup> percentile to the 99<sup>th</sup> percentile for gender, age, and height plus 5&#xA0;mmHg
[<xref ref-type="bibr" rid="B5">5</xref>]). Blood and urine investigations were consistent for acute renal insufficiency due to a nephritic-nephrotic syndrome (Table&#xA0;
<xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Blood and urine exams on admission</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="char" char="&#xD7;"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">&#xA0;</th>
              <th align="char" char="&#xD7;">
                <bold>Value</bold>
              </th>
              <th align="left">
                <bold>Reference range</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="bottom">
                <italic>Blood exams</italic>
                <hr/>
              </td>
              <td align="char" valign="bottom" char="&#xD7;">&#xA0;<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Red blood cells<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">4.2 x 10<sup>6</sup>/mmc<hr/></td>
              <td align="left" valign="bottom">3.9 &#x2013; 5.2 x 10<sup>6</sup>/mmc<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Hematocrit<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">39%<hr/></td>
              <td align="left" valign="bottom">34.5% - 42.5%<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Hemoglobin<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">12.2&#xA0;g/dL<hr/></td>
              <td align="left" valign="bottom">10.5 - 14.5&#xA0;g/dL<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;C-reactive protein<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">0.2&#xA0;mg/dL<hr/></td>
              <td align="left" valign="bottom">&lt; 0.5&#xA0;mg/dL<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;pH<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">7.39<hr/></td>
              <td align="left" valign="bottom">7.38 -7.42<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Sodium<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">138&#xA0;mEq/L<hr/></td>
              <td align="left" valign="bottom">135-145&#xA0;mEq/L<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Potassium<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">4.0&#xA0;mEq/L<hr/></td>
              <td align="left" valign="bottom">3.5 &#x2013; 5.0&#xA0;mE/L<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Ionized calcium<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">1.20&#xA0;mmol/L<hr/></td>
              <td align="left" valign="bottom">1.12 &#x2013; 1.32&#xA0;mmol/L<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Creatinine<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">1.1&#xA0;mg/dL<hr/></td>
              <td align="left" valign="bottom">&lt; 0.7&#xA0;mg/dL<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Nitrogen urea<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">100&#xA0;mg/dL<hr/></td>
              <td align="left" valign="bottom">15 &#x2013; 40&#xA0;mg/dL<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Albumin<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">3.0&#xA0;g/dL<hr/></td>
              <td align="left" valign="bottom">3.5 &#x2013; 5.0&#xA0;g/dL<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Complement C3<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">17&#xA0;mg/dL<hr/></td>
              <td align="left" valign="bottom">86 &#x2013; 184&#xA0;mg/dL<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Antistreptolysin titer<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">315 U/ml<hr/></td>
              <td align="left" valign="bottom">0 &#x2013; 200 U/ml<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <italic>Urine exams</italic>
                <hr/>
              </td>
              <td align="char" valign="bottom" char="&#xD7;">&#xA0;<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Protein/creatinin ratio<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">3.5 mg/mg<hr/></td>
              <td align="left" valign="bottom">&lt; 0.4&#xA0;mg/mg<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;Red cells number<hr/></td>
              <td align="char" valign="bottom" char="&#xD7;">55 per high-power field<hr/></td>
              <td align="left" valign="bottom">&lt; 5 per high-power field<hr/></td>
            </tr>
            <tr>
              <td align="left">&#x2003;Hyaline casts on sediment</td>
              <td align="char" char="&#xD7;">Present</td>
              <td align="left">Absent</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Since the 2<sup>nd</sup> day of hospitalization, the patient was treated with one bolus of methylprednisolone (15 mg/Kg) per day associated with strict blood pressure monitoring.</p>
      <p>On the 4<sup>th</sup> day of hospitalization, the patient developed severe headache associated with increased blood pressure up to 150/120&#xA0;mmHg (stage 2 hypertension: &gt; 99th percentile for gender, age and height plus 5&#xA0;mmHg
[<xref ref-type="bibr" rid="B5">5</xref>]). Alterations of conscious level, visual symptoms and vomiting were not present. Furthermore, cognitive dysfunctions, visual field defects, sensory abnormalities and ataxia were absent on the neurological examination.A brain MRI showed in fluid attenuated inversion recovery imaging (T2 coronal) high signal intensities in cerebellar white matter (Figure&#xA0;
<xref ref-type="fig" rid="F1">1</xref>A and C) and in parasagittal subcortical parietal regions (Figure&#xA0;
<xref ref-type="fig" rid="F2">2</xref>A and C). Diffusion weighted images did not show any restriction of diffusivity.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Brain MRI cerebellar features.</bold> MRI fluid attenuated inversion recovery (FLAIR) T2 images on axial <bold>(A)</bold> and coronal planes <bold>(C)</bold> showing high signal intensities in cerebellar white matter (indicated by the arrows). Follow up after 6&#xA0;days showing a complete resolution of the lesions on axial <bold>(B)</bold> and coronal planes <bold>(D)</bold>.</p>
        </caption>
        <graphic xlink:href="1471-2431-14-190-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Brain MRI parietal features.</bold> MRI fluid attenuated inversion recovery (FLAIR) T2 images on axial <bold>(A)</bold> and coronal planes <bold>(C)</bold> showing high signal intensities in parasagittal subcortical parietal regions (indicated by the arrows). Follow up after 6&#xA0;days showing a complete resolution of the lesions on axial <bold>(B)</bold> and coronal planes <bold>(D)</bold>.</p>
        </caption>
        <graphic xlink:href="1471-2431-14-190-2"/>
      </fig>
      <p>Methylprednisolone was discontinued. Candesartan was initiated and on 6<sup>th</sup> day of hospitalization, blood pressure normalized and both headache and periorbital edemas resolved. On 9<sup>th</sup> day of hospitalization, a control MRI showed complete regression of all the abnormalities (Figures&#xA0;
<xref ref-type="fig" rid="F1">1</xref>B, D and
<xref ref-type="fig" rid="F2">2</xref>B, D). Arterial hypertension, MRI findings and clinical outcome were consistent with the diagnosis of PRES.</p>
      <p>The child was discharged in good clinical condition without any further treatment.</p>
      <p>3 weeks later, clinical examination was unremarkable and blood pressure 105/70&#xA0;mmHg. Complement C3 and serum creatinine normalized and urinalysis revealed only persistent isolated microscopic hematuria (7 cells per high-power field).</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Posterior reversible encephalopathy syndrome has often been reported in pediatric cases associated with hypertension due to renal diseases or steroid treatment
[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>Symptoms usually include seizures, mental status changes, visual alterations, headache and vomiting
[<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>The literature describes posterior regions of the brain being frequently involved, but concomitant anterior lesions are often detected. Brain stem, basal ganglia, deep white matter, or splenium of the corpus callosum lesions are also described in less than one third of the patients
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. The pathophysiology of this syndrome is not fully understood, but appears to be multifactorial. The underlying mechanism could be a brain capillary leak syndrome following hypertension, fluid retention or cytotoxic effects of immunosuppressive agents on the vascular endothelium. A sudden rise in blood pressure is probably the most common cause. It can induce disruption of cerebral vascular auto-regulation, mostly in the posterior cerebral vasculature, causing leakage of fluid into the brain parenchyma
[<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. Indeed a gradual blood pressure control is recommended to avoid cerebral hypoperfusion and increased morbidity
[<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>Moreover this syndrome can be irreversible or even fatal if an appropriate treatment is not started promptly
[<xref ref-type="bibr" rid="B11">11</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>To the best of our knowledge, severe and isolated headache and hypertension have never been reported as unique clinical presentation of PRES. We speculate that the prompt recognition and treatment of this syndrome prevented its progression to the full blown syndrome.</p>
      <sec>
        <title>Consent</title>
        <p>The parents signed a case report consent for publication.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>MRI: Magnetic resonance imaging; PRES: Posterior reversible encephalopathy syndrome.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contribution</title>
      <p>GPM prepared the first draft and the last version of the manuscript and approved the final manuscript as submitted. AE had responsibility for the management of the patient, wrote the first draft of the manuscript, prepared the final draft of the manuscript and approved the final manuscript as submitted. GT reviewed the literature and approved the final manuscript as submitted. EA had responsibility for the management of the patient and approved the final manuscript as submitted. CMC had primary responsibility for the management of the patient and approved the final manuscript as submitted. EAL had primary responsibility for the management of the patient and approved the final manuscript as submitted. EL wrote the first draft of the manuscript and approved the final manuscript as submitted. AMC had responsibility for the management of the patient, wrote the first draft of the manuscript and approved the final manuscript as submitted. CA wrote the first draft of the manuscript and approved the final manuscript as submitted. EFF had primary responsibility for the management of the patient, wrote the first draft of the manuscript, reviewed the literature and approved the final manuscript as submitted.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2431/14/190/prepub">http://www.biomedcentral.com/1471-2431/14/190/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Financial disclosure</title>
      <p>Authors have no financial relationship relevant to this article to disclose.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hinchey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chaves</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Appignani</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Breen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pao</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pessin</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Lamy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mas</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Caplan</surname>
            <given-names>LR</given-names>
          </name>
          <article-title>A reversible posterior leukoencephalopathy syndrome</article-title>
          <source>N Engl J Med</source>
          <year>1996</year>
          <volume>334</volume>
          <fpage>494</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="pmid">8559202</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dillon</surname>
            <given-names>WP</given-names>
          </name>
          <name>
            <surname>Rowley</surname>
            <given-names>H</given-names>
          </name>
          <article-title>The reversible posterior cerebral edema syndrome</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>591</fpage>
          <pub-id pub-id-type="pmid">9541327</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Prasad</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gulati</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>RK</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>RK</given-names>
          </name>
          <article-title>Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?</article-title>
          <source>Pediatr Nephrol</source>
          <year>2003</year>
          <volume>18</volume>
          <issue>11</issue>
          <fpage>1161</fpage>
          <lpage>6</lpage>
          <comment>Nov</comment>
          <pub-id pub-id-type="pmid">14505162</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brannon Morris</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Laningham</surname>
            <given-names>FH</given-names>
          </name>
          <name>
            <surname>Sandlund</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>RB</given-names>
          </name>
          <article-title>Posterior Reversible Encephalopathy Syndrome in Children With Cancer</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>152</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">16317748</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <collab>National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents</collab>
          <article-title>The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents</article-title>
          <source>Pediatrics</source>
          <year>2004</year>
          <volume>114</volume>
          <fpage>555</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">15286277</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>G&#xFC;m&#xFC;&#x15F;</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Per</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kumanda&#x15F;</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yikilmaz</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature</article-title>
          <source>Neurol Sci</source>
          <year>2010</year>
          <volume>31</volume>
          <issue>2</issue>
          <fpage>125</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">19809787</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Froehlich</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sandifer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Varma</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Testa</surname>
            <given-names>FM</given-names>
          </name>
          <article-title>Two cases of hypertension-induced reversible posterior leukoencephalopathy syndrome secondary to glomerulonephritis</article-title>
          <source>Curr Opin Pediatr</source>
          <year>1999</year>
          <volume>11</volume>
          <fpage>512</fpage>
          <lpage>518</lpage>
          <pub-id pub-id-type="pmid">10590909</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lamy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Oppenheim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>M&#xE9;der</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Mas</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>Neuroimaging in posterior reversible encephalopathy syndrome</article-title>
          <source>J Neuroimaging</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>89</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">15095552</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Staykow</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Schwab</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Posterior reversible encephalopathy syndrome</article-title>
          <source>J Intensive Care Med</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>11</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">21257628</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Milani</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Bianchetti</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Mazzoni</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Triulzi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mauri</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Agostoni</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fossali</surname>
            <given-names>EF</given-names>
          </name>
          <article-title>Arterial hypertension and posterior reversible cerebral edema syndrome induced by risperidone</article-title>
          <source>Pediatrics</source>
          <year>2014</year>
          <volume>133</volume>
          <fpage>e771</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">24567018</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fugate</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Claassen</surname>
            <given-names>DO</given-names>
          </name>
          <name>
            <surname>Cloft</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Kallmes</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Kozak</surname>
            <given-names>OS</given-names>
          </name>
          <name>
            <surname>Rabinstein</surname>
            <given-names>AA</given-names>
          </name>
          <article-title>Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings</article-title>
          <source>Mayo Clin Proc</source>
          <year>2010</year>
          <volume>85</volume>
          <fpage>427</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">20435835</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
